e-Edition
Obituaries
In Loving Memory
Magazines
Subscribe
Login to Comment
Register
jobs
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Life
Commentary
Contact
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Novo Nordisk A/S Common Stock
(NY:
NVO
)
58.91
-0.73 (-1.22%)
Official Closing Price
Updated: 7:00 PM EST, Jan 14, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
16,344,126
Open
58.84
Bid (Size)
58.01 (300)
Ask (Size)
58.13 (900)
Prev. Close
59.64
Today's Range
58.34 - 59.75
52wk Range
43.08 - 93.80
Shares Outstanding
N/A
Dividend Yield
1.98%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
AbbVie Seeks To Grow Obesity Drug Portfolio — Retail Touts Drugmaker As Big Competition To Lilly
↗
Today 18:44 EST
Via
Stocktwits
VKTX, TERN, GPCR Shares Rally As Novo Nordisk Sounds Willingness Towards Portfolio-Expansion Deals
↗
Today 14:56 EST
Via
Stocktwits
Performance
YTD
+12.4%
+12.4%
1 Month
+17.0%
+17.0%
3 Month
+3.9%
+3.9%
6 Month
-12.1%
-12.1%
1 Year
-27.4%
-27.4%
More News
Read More
Slimmer Waistlines, Fatter Margins: Jefferies Says Airline Companies Will Profit From America’s Weight-Loss Boom
↗
Today 13:26 EST
Via
Stocktwits
Healthcare Sector Stages Resilient Rebound as Policy Clarity and GLP-1 Innovations Fuel Investor Optimism
Today 11:46 EST
Via
MarketMinute
Topics
Earnings
Economy
Is It Time to Dump Your Shares of Eli Lilly?
↗
Today 8:52 EST
Via
The Motley Fool
Topics
Intellectual Property
FDA Clears Popular Weight-Loss Drugs Of Suicide Risk After Review Of Over 100K Patients, Asks Drugmakers To Remove Warnings
↗
January 13, 2026
Via
Stocktwits
Why Is HIMS Stock Slipping Premarket Today?
↗
January 12, 2026
Via
Stocktwits
Eli Lilly Stock Rallies as Ventyx Deal Calms Wegovy Concerns
↗
January 13, 2026
Via
MarketBeat
The Great Recalibration: Why 2026 Could Be Healthcare’s Year to Rebound
January 13, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Intellectual Property
Amgen at the Crossroads: MariTide, Market Volatility, and the Quest for Obesity Dominance
January 13, 2026
Via
PredictStreet
Topics
Economy
Intellectual Property
Eli Lilly vs Novo Nordisk: Which Company Will Dominate the Weight Loss Drug Market in 2026?
↗
January 13, 2026
Via
The Motley Fool
Can Novo Nordisk Unseat Eli Lilly as the Weight Loss Drug Leader in 2026?
↗
January 13, 2026
Via
The Motley Fool
Why Tempus AI Stock Rose Today
↗
January 12, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Beyond the Protein: How AlphaFold 3 Redefined the Blueprint of Life and Accelerated the Drug Discovery Revolution
January 12, 2026
Via
TokenRing AI
Topics
Artificial Intelligence
Anthropic Launches “Claude for Healthcare”: A Paradigm Shift in Medical AI Integration and HIPAA Security
January 12, 2026
Via
TokenRing AI
Topics
Artificial Intelligence
From Silicon to Syringes: Nvidia’s AI Dominance Solidified Through Landmark Eli Lilly Alliance
January 12, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Intellectual Property
The Convergence of Silicon and Science: Eli Lilly and Nvidia Unveil $1 Billion AI Co-Innovation Lab at JPM26
January 12, 2026
Via
MarketMinute
Topics
Artificial Intelligence
An Investor's Guide to 2026
↗
January 12, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Economy
Stocks to Love in 2026
↗
January 11, 2026
Via
The Motley Fool
Topics
ETFs
Initial Public Offering
This ETF Is Proof That the Healthcare Rebound Is Real
↗
January 11, 2026
Via
MarketBeat
Topics
ETFs
This Healthcare Stock Could Be One of the Best Companies to Own in 2026
↗
January 11, 2026
Via
The Motley Fool
Eli Lilly Solidifies Immunology Dominance with $1.2 Billion Acquisition of Ventyx Biosciences
January 09, 2026
Via
MarketMinute
The Great Pricing Pivot: Novo Nordisk Launches Wegovy Pill in Bid to Reclaim US Market Dominance
January 09, 2026
Via
MarketMinute
Topics
Economy
The Trillion-Dollar Pharmacist: A 2026 Deep Dive into Eli Lilly (LLY)
January 09, 2026
Via
PredictStreet
Topics
Earnings
Economy
Intellectual Property
Nvidia’s $5 Trillion Peak Sparks Massive Nasdaq Retreat as Investors Pivot to Value
January 08, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Stocks
Frequently Asked Questions
Is Novo Nordisk A/S Common Stock publicly traded?
Yes, Novo Nordisk A/S Common Stock is publicly traded.
What exchange does Novo Nordisk A/S Common Stock trade on?
Novo Nordisk A/S Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novo Nordisk A/S Common Stock?
The ticker symbol for Novo Nordisk A/S Common Stock is NVO on the New York Stock Exchange
What is the current price of Novo Nordisk A/S Common Stock?
The current price of Novo Nordisk A/S Common Stock is 58.91
When was Novo Nordisk A/S Common Stock last traded?
The last trade of Novo Nordisk A/S Common Stock was at 01/14/26 07:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
wpDiscuz
Insert